Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Dexcom Inc banner

Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 89.69 USD 2% Market Closed
Market Cap: $34.6B
Write Note Create Alert Ask AI

Wall St Price Targets

DXCM Price Targets Summary
Dexcom Inc

Wall Street analysts forecast DXCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXCM is 95.88 USD with a low forecast of 75.75 USD and a high forecast of 120.75 USD.

DXCM Lowest Forecast
Wall Street Target
$75.75
-16% Downside
DXCM Average Forecast
Wall Street Target
$95.88
7% Upside
DXCM Highest Forecast
Wall Street Target
$120.75
35% Upside
Lowest Forecast
Price Target
75.75 USD
16% Downside
Average Forecast
Price Target
95.88 USD
7% Upside
Highest Forecast
Price Target
120.75 USD
35% Upside
Dexcom Inc Competitors:
Price Targets

Revenue
Forecast

34% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
34% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 12%.

What are analyst estimates?

Gross Profit
Forecast

37% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
37% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 5 years is 14%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

The compound annual growth rate for Operating Income over the next 5 years is 19%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

The compound annual growth rate for Net Income over the next 5 years is 19%.

What are analyst estimates?

Continue DXCM Research

Summary
DXCM intrinsic value, competitors valuation, and company profile.
DCF Valuation
DXCM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DXCM stock valuation using valuation multiples.
Wall St Estimates
DXCM price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DXCM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Dexcom Inc listings:
F • EUR
DC4
 XMUN • EUR
DC4
 SWB • EUR
DC4
 XETRA • EUR
DC4
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DXCM's stock price target?
Price Target
95.88 USD

According to Wall Street analysts, the average 1-year price target for DXCM is 95.88 USD with a low forecast of 75.75 USD and a high forecast of 120.75 USD.

What is the Revenue forecast for Dexcom Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 12%.

What is the Gross Profit forecast for Dexcom Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 37%. The projected CAGR for the next 5 years is 14%.

What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
19%

The compound annual growth rate for Operating Income over the next 5 years is 19%.

What is the Pre-Tax Income forecast for Dexcom Inc?
Projected CAGR
19%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.

What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%

The compound annual growth rate for Net Income over the next 5 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.